Frequently Asked Questions How much protein should I eat on GLP-1 medications
Risk factors include acute illness, reduced food intake, alcohol excess, and insulin dose reduction
Insomnia is not listed in the FDA prescribing information for tirzepatide and was not identified as a statistically significant adverse event in clinical trials
Bacterial biofilms predominate in both acute and chronic human lung infections
The timing of any combination of treatments will be agreed upon during consultation
Taken together, these findings suggest that GLP-1RAs are poised to reshape the therapeutic landscape by integrating metabolic, cardiovascular, renal, hepatic, and potentially neurological benefits